Insider: Harris Todd President and CEO - Tyra Biosciences, Inc.
| Company Holdings |
| Direct | Indirect Ownership | Total | |
| Shares | 1,355,927 | 0 | 1,355,927 |
| Value | $51,904,885.56 | $0.00 | $51,904,885.56 |
Trans. Date |
Trans. Type |
Shares |
Ownership Type |
Issue Type |
Price |
Trans. Value |
Total Shares Owned |
|---|---|---|---|---|---|---|---|
| 10/21/2024 | DDS | 13,188 | Direct | COM | $28.16 | $371,370.12 | 1,355,927 |
| 10/21/2024 | DDS | 5,896 | Direct | COM | $27.32 | $161,081.08 | 1,369,115 |
| 10/18/2024 | DDS | 43,636 | Direct | COM | $27.01 | $1,178,795.99 | 1,375,011 |
| 10/17/2024 | DDS | 15,194 | Direct | COM | $25.84 | $392,597.77 | 1,418,847 |
| 10/17/2024 | DDS | 200 | Direct | COM | $26.37 | $5,274.00 | 1,418,647 |
| 10/16/2024 | DDS | 4,900 | Direct | COM | $25.22 | $123,555.95 | 1,462,438 |
| 10/16/2024 | DDS | 24,475 | Direct | COM | $26.23 | $642,062.47 | 1,437,963 |
| 10/16/2024 | DDS | 3,922 | Direct | COM | $26.98 | $105,811.25 | 1,434,041 |
| 10/15/2024 | DDS | 10,035 | Direct | COM | $24.31 | $243,969.92 | 1,467,338 |
| 09/30/2024 | DDS | 500 | Direct | COM | $24.00 | $12,000.00 | 1,477,373 |
| 09/25/2024 | DDS | 600 | Direct | COM | $24.01 | $14,406.00 | 1,477,873 |
| 09/24/2024 | DDS | 1,055 | Direct | COM | $24.02 | $25,340.68 | 1,478,473 |
| 09/23/2024 | DDS | 10,092 | Direct | COM | $24.13 | $243,476.56 | 1,479,528 |
| 09/20/2024 | DDS | 7,109 | Direct | COM | $24.19 | $171,950.36 | 1,489,620 |
| 09/19/2024 | DDS | 27 | Direct | COM | $25.10 | $677.62 | 1,496,729 |
| 09/19/2024 | DDS | 5,671 | Direct | COM | $24.30 | $137,813.24 | 1,496,756 |
| 09/18/2024 | DDS | 3,500 | Direct | COM | $24.00 | $84,000.00 | 1,502,427 |
| 02/05/2024 | DDS | 13,817 | Direct | COM | $16.97 | $234,430.28 | 1,502,697 |
| 02/02/2024 | DDS | 78,996 | Direct | COM | $16.45 | $1,299,160.32 | 1,523,701 |
| 02/02/2024 | DDS | 7,187 | Direct | COM | $17.04 | $122,494.51 | 1,516,514 |
| 06/23/2023 | DDS | 14,231 | Direct | COM | $16.78 | $238,797.60 | 1,607,757 |
| 06/23/2023 | DDS | 6,481 | Direct | COM | $17.51 | $113,463.52 | 1,601,276 |
| 06/22/2023 | DDS | 2,978 | Direct | COM | $16.98 | $50,558.10 | 1,622,488 |
| 06/22/2023 | DDS | 500 | Direct | COM | $17.39 | $8,693.00 | 1,621,988 |
| 06/21/2023 | DDS | 4,629 | Direct | COM | $16.12 | $74,614.85 | 1,640,593 |
| 1 2 Next Last You are at page 1 of 2 pages |
|
Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust |
 |
Send to Excel |
© 2000 - 2026 Zacks Investment Research